Elevance Health Statistics Share Statistics Elevance Health has 237.46M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 237.46M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 237.04M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 2.27M, so 0% of the outstanding
shares have been sold short.
Short Interest 2.27M Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 2.53
Valuation Ratios The PE ratio is 14.37 and the forward
PE ratio is null.
Elevance Health's PEG ratio is
8.48.
PE Ratio 14.37 Forward PE n/a PS Ratio 0.49 Forward PS n/a PB Ratio 2.08 P/FCF Ratio 18.87 PEG Ratio 8.48
Financial Ratio History Enterprise Valuation Elevance Health has an Enterprise Value (EV) of 108.85B.
EV / Sales 0.62 EV / EBITDA 10.38 EV / EBIT 18.74 EV / FCF 23.91
Financial Position The company has a current ratio of 2.01,
with a Debt / Equity ratio of 0.76.
Current Ratio 2.01 Quick Ratio 2.01 Debt / Equity 0.76 Debt / EBITDA 2.98 Debt / FCF 6.86 Interest Coverage 6.67
Financial Efficiency Return on Equity is 14.47% and Return on Invested Capital is 6.44%.
Return on Equity 14.47% Return on Assets 5.12% Return on Invested Capital 6.44% Revenue Per Employee $1.8M Profits Per Employee $60.9K Employee Count 98,200 Asset Turnover 1.51 Inventory Turnover n/a
Taxes Income Tax 1.93B Effective Tax Rate 24.46%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0.97, so Elevance Health's
price volatility has been higher than the market average.
Beta 0.97 52-Week Price Change n/a 50-Day Moving Average 493.45 200-Day Moving Average n/a Relative Strength Index (RSI) 51.21 Average Volume (20 Days) 1,177,335
Income Statement In the last 12 months, Elevance Health had revenue of 176.81B
and earned 5.98B
in profits. Earnings per share was 25.81.
Revenue 176.81B Gross Profit 176.81B Operating Income 7.9B Net Income 5.98B EBITDA 10.48B EBIT 9.09B Earnings Per Share (EPS) 25.81
Full Income Statement Balance Sheet The company has 8.29B in cash and 31.23B in
debt, giving a net cash position of -22.94B.
Cash & Cash Equivalents 8.29B Total Debt 31.23B Net Cash -22.94B Retained Earnings 33.55B Total Assets 100.82B Working Capital 29.28B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 5.81B
and capital expenditures -1.26B, giving a free cash flow of 4.55B.
Operating Cash Flow 5.81B Capital Expenditures -1.26B Free Cash Flow 4.55B FCF Per Share 19.55
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of 4.47% and 3.38%.
Gross Margin 100% Operating Margin 4.47% Pretax Margin 4.47% Profit Margin 3.38% EBITDA Margin 5.93% EBIT Margin 4.47% FCF Margin 2.57%
Dividends & Yields ANTM pays an annual dividend of $5.95,
which amounts to a dividend yield of 0.99%.
Dividend Per Share $5.95 Dividend Yield 0.99% Dividend Growth (YoY) 13.27% Payout Ratio 23.42% Earnings Yield 6.96% FCF Yield 5.3%
Dividend Details Analyst Forecast Currently there are no analyst rating for ANTM.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $185.83 Lynch Upside -61.49% Graham Number 320.18 Graham Upside -33.65%
Stock Splits The last stock split was on Jun 1, 2005. It was a
forward
split with a ratio of 2:1.
Last Split Date Jun 1, 2005 Split Type forward Split Ratio 2:1
Scores Altman Z-Score 3.57 Piotroski F-Score 8
